Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Colorcon
Accenture
Healthtrust
UBS
Fish and Richardson
AstraZeneca
McKesson
Baxter
Chinese Patent Office

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,063,029

« Back to Dashboard

Which drugs does patent 8,063,029 protect, and when does it expire?


Patent 8,063,029 protects TESTIM and is included in one NDA. There has been one Paragraph IV challenge on Testim.

This patent has forty-five patent family members in twenty-nine countries.

Summary for Patent: 8,063,029

Title:Pharmaceutical composition
Abstract: A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening agent; including, for example, a composition in which the cyclic enhancer is a macrocyclic ester or a macrocyclic ketone; the use of the composition to treat a condition, for example, male hypogonadism, in a patient by applying the composition to the membrane of the patient; and a method for making the composition.
Inventor(s): Gyurik; Robert J. (Exeter, NH)
Assignee: FCB I LLC (Wilmington, DE)
Application Number:11/930,812
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Auxilium Pharms Llc
TESTIM
testosterone
GEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe METHOD FOR ADMINISTRATION OF TESTOSTERONE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,063,029

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,608,608Pharmaceutical composition► Subscribe
7,320,968Pharmaceutical composition► Subscribe
7,935,690Pharmaceutical composition► Subscribe
8,178,518Pharmaceutical composition► Subscribe
7,608,606Pharmaceutical composition► Subscribe
7,608,607Pharmaceutical composition► Subscribe
7,608,609Pharmaceutical composition► Subscribe
7,608,605Pharmaceutical composition► Subscribe
7,608,610Pharmaceutical composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,063,029

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina039644► Subscribe
Argentina087484► Subscribe
Austria371456► Subscribe
Australia2003228612► Subscribe
Brazil0309390► Subscribe
Canada2470200► Subscribe
China102357098► Subscribe
China1662243► Subscribe
Cyprus1109005► Subscribe
Germany60315939► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Express Scripts
Farmers Insurance
Harvard Business School
Cantor Fitzgerald
US Department of Justice
Chubb
UBS
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot